asoxime chloride

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







72 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33538594 Structural and Biochemical Insights into the Inhibition of Human Acetylcholinesterase by G-Series Nerve Agents and Subsequent Reactivation by HI-6. 2021 Mar 15 3
2 33831382 Effects of memantine and its metabolite Mrz 2/373 on soman-induced inhibition of acetylcholinesterase in vitro. 2021 Jun 1 1
3 32175496 Molecular Modeling Study of Uncharged Oximes Compared to HI-6 and 2-PAM Inside Human AChE Sarin and VX Conjugates. 2020 Mar 10 2
4 32267631 A novel high-performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme-reactivating oximes obidoxime, pralidoxime, and HI-6 in human plasma. 2020 Jul 2
5 30763608 Human small bowel as model for poisoning with organophosphorus compounds. 2019 Jun 1
6 30858091 The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM). 2019 Jun 15 1
7 28446076 Behavior of uncharged oximes compared to HI6 and 2-PAM in the human AChE-tabun conjugate: a molecular modeling approach. 2018 May 3
8 28993240 The oximes HI-6 and MMB-4 fail to reactivate soman-inhibited human and guinea pig AChE: A kinetic in vitro study. 2018 Sep 1 1
9 29019446 The role of the oximes HI-6 and HS-6 inside human acetylcholinesterase inhibited with nerve agents: a computational study. 2018 Oct 1
10 29735900 Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon. 2018 May 7 1
11 29773682 Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase. 2018 Jun 29 2
12 30312685 Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro. 2018 Dec 15 1
13 30462502 Structural Insights of Stereospecific Inhibition of Human Acetylcholinesterase by VX and Subsequent Reactivation by HI-6. 2018 Dec 17 2
14 27358236 Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6. 2017 Mar 1
15 27153754 Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics. 2016 Mar 28 3
16 27179675 A liquid chromatography tandem mass spectrometric method on in vitro nerve agents poisoning characterization and reactivator efficacy evaluation by determination of specific peptide adducts in acetylcholinesterase. 2016 Jun 10 1
17 27191504 Structures of paraoxon-inhibited human acetylcholinesterase reveal perturbations of the acyl loop and the dimer interface. 2016 Sep 1
18 26468911 Protein-Drug Interactions with Effective Polarization in Polarizable Water: Oxime Unbinding from AChE Gorge. 2015 Nov 12 1
19 25240274 Reactions of methylphosphonic difluoride with human acetylcholinesterase and oximes--Possible therapeutic implications. 2014 Nov 18 2
20 22982773 A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds. 2013 Mar 25 2
21 23111374 Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents. 2013 Mar 25 1
22 23376121 Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity. 2013 May 1 6
23 23917882 Acetylcholinesterase reactivators (HI-6, obidoxime, trimedoxime, K027, K075, K127, K203, K282): structural evaluation of human serum albumin binding and absorption kinetics. 2013 Aug 2 1
24 23936743 Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus. 2013 Aug 1
25 22360473 Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. 2012 May 15 1
26 22447833 Cytotoxicity and genotoxicity evaluation of antidote oxime HI-6 tested on eight cell lines of human and rodent origin. 2012 Mar 1
27 23030612 Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data. 2012 1
28 20027669 Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. 2011 Jul 2
29 21451868 First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase. 2011 May 14 1
30 21673941 In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase. 2011 2
31 21730071 Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. 2011 Aug 26 1
32 21803135 Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6. 2011 Sep 25 1
33 20417629 Interactions of pyridinium oximes with acetylcholinesterase. 2010 Sep 6 2
34 20655881 Y124 at the peripheral anionic site is important for the reactivation of nerve agent-inhibited acetylcholinesterase by H oximes. 2010 Nov 1 1
35 20888357 Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach. 2010 Dec 15 1
36 19356117 Study of efficacy of reactivator HI 6 in reactivation of immobilized acetylcholinesterase, inhibited by organophosphorus chemical warfare agents of the "G" series. 2009 Jan 1
37 19429253 Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study. 2009 Jun 1 1
38 19519385 Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. 2009 1
39 19651196 Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. 2009 Oct 28 1
40 19663821 Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach. 2009 Dec 2
41 19761810 Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis. 2009 Nov 30 1
42 18804659 Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators. 2008 Oct 19 1
43 20020898 In Vitro Comparison of Two Most Promising H-Oximes (HI-6 and HLö-7) and Currently Commercially Available Reactivators Pralidoxime and Obidoxime in Reactivation of Cyclosarin-Inhibited Human Cholinesterases. 2008 1
44 17370251 Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. 2007 Nov-Dec 2
45 17713603 Evaluation of HI-6 oxime: potential use in protection of human acetylcholinesterase inhibited by antineoplastic drug irinotecan and its cyto/genotoxicity in vitro. 2007 1
46 17900152 An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes. 2007 Oct 23 1
47 17913691 Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status: important indicators for the treatment of patients poisoned by organophosphorus compounds. 2007 Sep 1
48 18254274 Evaluation of potency of known oximes (pralidoxime, trimedoxime, HI-6, methoxime, obidoxime) to in vitro reactivate acetylcholinesterase inhibited by pesticides (chlorpyrifos and methylchlorpyrifos) and nerve agent (Russian VX). 2007 3
49 16740352 Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning. 2006 Jul 5 1
50 17252938 Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases. 2006 Dec 1